NCT06585761View on ClinicalTrials.gov

Effect of Sodium Glucose Co-tansporter 2 Inhibitors (SGLT2I) on Inflammatory and Oxidative Stress Markers Level in Heart Failure Patients

RecruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

February 15, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Heart Failure
Interventions
DRUG

SGLT2 inhibitor

patients with HF are subjected to regular dose of SGLT2I member according to patient status.

DEVICE

echo cardiogram

the patients are subjected to ECHO to determine their EF prior to and post the study

Trial Locations (1)

33516

RECRUITING

Kafrelsheikh University Hospital, Kafr ash Shaykh

All Listed Sponsors
lead

Kafrelsheikh University

OTHER